TVTX logo

Travere Therapeutics, Inc. (TVTX) Total assets

annual total assets:

$594.13M-$194.79M(-24.69%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual total assets is $594.13 million, with the most recent change of -$194.79 million (-24.69%) on December 31, 2024.
  • During the last 3 years, TVTX annual total assets has fallen by -$182.51 million (-23.50%).
  • TVTX annual total assets is now -24.69% below its all-time high of $788.91 million, reached on December 31, 2023.

Performance

TVTX Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

quarterly total assets:

$555.31M+$6.51M(+1.19%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly total assets is $555.31 million, with the most recent change of +$6.51 million (+1.19%) on June 30, 2025.
  • Over the past year, TVTX quarterly total assets has increased by +$4.19 million (+0.76%).
  • TVTX quarterly total assets is now -33.32% below its all-time high of $832.85 million, reached on September 30, 2023.

Performance

TVTX quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

TVTX Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-24.7%+0.8%
3 y3 years-23.5%-28.8%
5 y5 years-1.8%-18.2%

TVTX Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-24.7%at low-33.3%+10.1%
5 y5-year-24.7%at low-33.3%+10.1%
alltimeall time-24.7%>+9999.0%-33.3%>+9999.0%

TVTX Total assets History

DateAnnualQuarterly
Jun 2025
-
$555.31M(+1.2%)
Mar 2025
-
$548.80M(-7.6%)
Dec 2024
$594.13M(-24.7%)
$594.13M(+17.8%)
Sep 2024
-
$504.41M(-8.5%)
Jun 2024
-
$551.12M(-16.9%)
Mar 2024
-
$663.55M(-15.9%)
Dec 2023
$788.91M(+17.3%)
$788.91M(-5.3%)
Sep 2023
-
$832.85M(+13.1%)
Jun 2023
-
$736.43M(-8.9%)
Mar 2023
-
$808.23M(+20.2%)
Dec 2022
$672.59M(-13.4%)
$672.59M(-7.4%)
Sep 2022
-
$726.22M(-6.8%)
Jun 2022
-
$779.49M(-5.9%)
Mar 2022
-
$828.40M(+6.7%)
Dec 2021
$776.63M(+27.9%)
$776.63M(+0.2%)
Sep 2021
-
$775.08M(+3.8%)
Jun 2021
-
$746.77M(-2.3%)
Mar 2021
-
$764.04M(+25.8%)
Dec 2020
$607.44M(+0.4%)
$607.44M(-12.2%)
Sep 2020
-
$692.22M(+2.0%)
Jun 2020
-
$678.69M(+18.4%)
Mar 2020
-
$573.06M(-5.2%)
Dec 2019
$604.80M(-18.5%)
$604.80M(-1.5%)
Sep 2019
-
$613.82M(-5.2%)
Jun 2019
-
$647.57M(-3.0%)
Mar 2019
-
$667.67M(-10.0%)
Dec 2018
$741.87M(+38.1%)
$741.87M(+3.6%)
Sep 2018
-
$716.19M(+45.8%)
Jun 2018
-
$491.14M(-1.9%)
Mar 2018
-
$500.79M(-6.8%)
Dec 2017
$537.16M
$537.16M(+3.2%)
Sep 2017
-
$520.51M(+2.6%)
Jun 2017
-
$507.13M(-0.6%)
DateAnnualQuarterly
Mar 2017
-
$510.38M(-10.1%)
Dec 2016
$567.56M(+4.6%)
$567.56M(+6.6%)
Sep 2016
-
$532.42M(-0.3%)
Jun 2016
-
$533.97M(+5.3%)
Mar 2016
-
$507.10M(-1.0%)
Dec 2015
$542.37M(+300.4%)
$512.40M(+0.2%)
Sep 2015
-
$511.63M(+20.3%)
Jun 2015
-
$425.14M(+2.2%)
Mar 2015
-
$415.99M(+207.1%)
Dec 2014
$135.47M(+560.9%)
$135.47M(-7.2%)
Sep 2014
-
$145.93M(-6.2%)
Jun 2014
-
$155.54M(+65.4%)
Mar 2014
-
$94.05M(+358.8%)
Dec 2013
$20.50M(+757.2%)
$20.50M(-4.1%)
Sep 2013
-
$21.36M(+699.4%)
Jun 2013
-
$2.67M(-46.0%)
Mar 2013
-
$4.95M(+107.0%)
Dec 2012
$2.39M(>+9900.0%)
$2.39M(>+9900.0%)
Nov 2011
-
$3900.00(0.0%)
Aug 2011
-
$3900.00(0.0%)
May 2011
-
$3900.00(-2.5%)
Feb 2011
$4000.00(-13.0%)
$4000.00(-11.1%)
Nov 2010
-
$4500.00(-2.2%)
Aug 2010
-
$4600.00(0.0%)
May 2010
-
$4600.00(0.0%)
Feb 2010
$4600.00(-4.2%)
$4600.00(-2.1%)
Nov 2009
-
$4700.00(0.0%)
Aug 2009
-
$4700.00(-2.1%)
May 2009
-
$4800.00(0.0%)
Feb 2009
$4800.00(>+9900.0%)
$4800.00(0.0%)
Nov 2008
-
$4800.00(-4.0%)
Aug 2008
-
$5000.00(0.0%)
May 2008
-
$5000.00
Feb 2008
$0.00
-

FAQ

  • What is Travere Therapeutics, Inc. annual total assets?
  • What is the all time high annual total assets for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual total assets year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly total assets?
  • What is the all time high quarterly total assets for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly total assets year-on-year change?

What is Travere Therapeutics, Inc. annual total assets?

The current annual total assets of TVTX is $594.13M

What is the all time high annual total assets for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual total assets is $788.91M

What is Travere Therapeutics, Inc. annual total assets year-on-year change?

Over the past year, TVTX annual total assets has changed by -$194.79M (-24.69%)

What is Travere Therapeutics, Inc. quarterly total assets?

The current quarterly total assets of TVTX is $555.31M

What is the all time high quarterly total assets for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly total assets is $832.85M

What is Travere Therapeutics, Inc. quarterly total assets year-on-year change?

Over the past year, TVTX quarterly total assets has changed by +$4.19M (+0.76%)
On this page